India’s first dengue vaccine, Qdenga, offers protection against all four strains, reducing severe illness risk. Experts say ...
Takeda’s dengue fever vaccine Qdenga has demonstrated its long-term benefits against infection and hospitalisation in a Phase III trial. During the TIDES study (NCT02747927), two doses of the live, ...
The vaccine to be considered for introduction in settings with high dengue disease burden and high transmission intensity to maximize the public health impact and minimize any potential risk in ...
India's high burden of dengue cases may soon see some relief thanks to a new vaccine from Japanese company Takeda, The Times of India reported. Dengue fever is transmitted through mosquito bites that ...
A new vaccine and an antiviral treatment for dengue fever are being hailed as breakthroughs in the global fight against the mosquito-borne disease. The one-dose vaccine, which has been approved for ...
Discover how arbovirus E Dimer vaccines are engineered to improve safety by minimizing antibody dependent enhancement.
​India reported over 2.89 lakh dengue cases in 2023, though experts believe the actual burden could be significantly higher ...
MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program Study will evaluate a single dose of V181 for the prevention of dengue disease ...
In a new study, scientists have discovered more about how the body protects against dengue fever, one of the world's most common mosquito-borne illnesses, prompting hopes for more effective vaccines ...
The first vaccine formulated to combat dengue fever, a virus spread by the same mosquito responsible for Zika, has launched in the Philippines, according to a CNN report. Dengue fever infects nearly ...
A vaccine against Dengue fever has been developed in Russia, and clinical trials are beginning. This was announced on April ...
Following the first locally recorded case of dengue fever in Hong Kong, here is what to know about the symptoms, risks, and ...